This NDC is on FDA's drug shortage list (posted Jun 13, 2018)

Reported reason: Demand increase for the drug

Product Information

LIDOCAINE HCL 1% VIAL is a generic product labeled by Eugia US LLC, priced at $0.0716 per ML under NDC 55150025220. Its NADAC has been published 287 times since May 20, 2020.

FDA first approved this application on Oct 30, 2017. Its Orange Book therapeutic-equivalence code is AP.

LIDOCAINE HCL 1% VIAL

Lidocaine Hydrochloride
$0.0716per ML

Strength

10 mg/mL

Manufacturer

Eugia US LLC

NDC

55150025220

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INFILTRATION; PERINEURAL

Effective Date

10/21/2026

Active Ingredients

LIDOCAINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207182

FDA Approved

10/30/2017

TE Code

AP

On Market Since

10/30/2017

Pharmacological Classes

Price Statistics

The NADAC for LIDOCAINE HCL 1% VIAL has been published 287 times since May 20, 2020, and over the history we have for it it has risen 6.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0716 per ML
All-time high$0.0853 (Apr 10, 2024)
All-time low$0.0582 (Oct 18, 2023)
52-week high$0.0762
52-week low$0.0681
Median price$0.0703
Average price$0.0697
Largest weekly change+46.6% (Dec 20, 2023)
Weeks tracked287
Tracking sinceMay 20, 2020

Price History

1W

0.0%

1M

+2.3%

3M

+5.2%

6M

-5.1%

1Y

-5.2%

3Y

+23.1%

5Y

+18.1%

All

+6.9%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LIDOCAINE HCL 1% VIAL?

The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 1% VIAL, manufactured by Eugia US LLC, is $0.0716 per ML (NDC 55150025220), effective Nov 11, 2026.

How has the price of LIDOCAINE HCL 1% VIAL changed over time?

Over the history we have for it, the NADAC for LIDOCAINE HCL 1% VIAL has risen 6.9%. It has been tracked across 287 weekly CMS publications since May 20, 2020.

What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 1% VIAL?

Since May 20, 2020, the NADAC for LIDOCAINE HCL 1% VIAL has ranged from a low of $0.0582 (Oct 18, 2023) to a high of $0.0853 (Apr 10, 2024), with a median of $0.0703 per ML.

Are there cheaper alternatives to LIDOCAINE HCL 1% VIAL?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE HCL 1% 300 MG/30 ML, is $0.0688 per ML — about 4% below LIDOCAINE HCL 1% VIAL.

Who manufactures LIDOCAINE HCL 1% VIAL?

LIDOCAINE HCL 1% VIAL (NDC 55150025220) is labeled by Eugia US LLC, and CMS classifies it as a generic product.

Is LIDOCAINE HCL 1% VIAL in shortage?

Yes — NDC 55150025220 is currently listed in FDA's drug shortage database (posted Jun 13, 2018). Reported reason: Demand increase for the drug.